| Age: median (range) | 54 (24-73) |
| Sex | 21M:19F |
| Stage of disease | |
| First relapse | 20 |
| ≥Second relapse | 20 |
| Prior stem cell transplant | |
| Allogeneic | 14 |
| Autologous | 4 |
| None | 22 |
| Cytogenetic abnormality | |
| t(8;21) | 1 |
| inv(16) | 2 |
| t(4;11) | 1 |
| t(6;11) | 1 |
| t(9;11) | 2 |
| Complex abnormality | 22 |
| None detected | 10 |
| Unknown | 1 |
| Prior myelodysplastic phase | |
| Present | 9 |
| Absent | 31 |
| Age: median (range) | 54 (24-73) |
| Sex | 21M:19F |
| Stage of disease | |
| First relapse | 20 |
| ≥Second relapse | 20 |
| Prior stem cell transplant | |
| Allogeneic | 14 |
| Autologous | 4 |
| None | 22 |
| Cytogenetic abnormality | |
| t(8;21) | 1 |
| inv(16) | 2 |
| t(4;11) | 1 |
| t(6;11) | 1 |
| t(9;11) | 2 |
| Complex abnormality | 22 |
| None detected | 10 |
| Unknown | 1 |
| Prior myelodysplastic phase | |
| Present | 9 |
| Absent | 31 |